A Study of Ramucirumab (LY3009806) in Healthy Participants
Clinical trial NCT04495478 · COMPLETED
Trial details
- NCT number
- NCT04495478
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-30
- Primary completion
- 2021-05-09
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.